voriconazole has been researched along with AIDS Seroconversion in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bearman, G; Beaulieu, C; Fulco, PP; Higginson, RT | 1 |
Das, PP; Nath, R; Phukan, SK; Saikia, L | 1 |
Guggemos, W; Hecht, A; RĂ¼disser, K; Seilmaier, M | 1 |
Horstkotte, MA; Rohde, H; Sobottka, I; Steininger, C; Stellbrink, HJ; van Lunzen, J | 1 |
4 other study(ies) available for voriconazole and AIDS Seroconversion
Article | Year |
---|---|
Pharmacogenetic testing for the treatment of aspergillosis with voriconazole in two HIV-positive patients.
Topics: Anti-Retroviral Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Drug Dosage Calculations; HIV Seropositivity; Humans; Male; Middle Aged; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Voriconazole | 2019 |
Species distribution & antifungal susceptibility pattern of oropharyngeal Candida isolates from human immunodeficiency virus infected individuals.
Topics: Adolescent; Adult; Aged; Antiretroviral Therapy, Highly Active; Candida; Candidiasis; Child; Child, Preschool; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Female; Fluconazole; HIV; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Oropharynx; Voriconazole | 2016 |
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2009 |
Mycotic brain abscess caused by opportunistic reptile pathogen.
Topics: Adult; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Chrysosporium; HIV Seropositivity; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |